Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fresh Day Meds vs Obu Health

Fresh Day Meds
Graded #25

Higher grade

vs+24.4
Obu Health
Graded #332

Lower grade

The verdict

Fresh Day Meds takes it — 84.3/100 to 59.9/100.

Fresh Day Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tight both-molecule spread ($133/$166), verified and nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFresh Day Meds +44
88
44
Dose & formulationFresh Day Meds +16
80
64
Clinical oversightEven
84
84
Labs & monitoringFresh Day Meds +29
82
53
FulfillmentFresh Day Meds +13
87
74
Contract termsFresh Day Meds +54
85
31
Fresh Day Meds · left barObu Health · right bar

The numbers

MetricFresh Day MedsObu Health
WeighScore84.3/10059.9/100
GradeBC
Scorecard rank#25#332
Semaglutide$133/mo$190/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$166/mo$239/mo (starting dose, plus a separate fee, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Fresh Day Meds

Graded #25 · B

Strengths

  • $133 sema / $166 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Injection-only
  • Monitoring detail not published
  • Newer brand
Obu Health

Graded #332 · C

Strengths

  • LegitScript-certified with publicly displayed ID (44206977)
  • Two named 503A compounding-pharmacy partners (Manifest Pharmacy SC + RX Compounding Store FL) — transparency above category baseline
  • Lower advertised semaglutide starting price ($190) than most multi-product peer platforms
  • Multi-product offering (GLP-1s + NAD+ + sermorelin + generic ED + birth control) for single-platform users
  • 24-hour US board-certified physician response window

Where it loses points

  • Per-dose pricing tiers not transparently published on product pages — only 'starting from' prices visible
  • No explicit state-coverage list disclosed; FAQ confirms restrictions exist 'based on state' without enumeration
  • Medical director not named publicly
  • No published consultation fee disclosure — unclear whether physician visit is included in medication price
  • All sales final per FAQ ('Federal and State law do not allow medication returns')

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard